Abstract:Metabolites have been recognized as biomarkers for diagnostic testing and monitoring of many diseases (1). However, in comparison to many clinical tests that target nucleic acids and proteins, detection and quantification of metabolites, including those applied in point-of-care (POC)2 settings, have been less developed, despite the proven success of glucometers widely used by diabetics. A major contributing factor is the lack of methods that, once developed, can be generalized and applied to many other metabolites. Without such generalizable methods, the costs of development become higher and the resulting tests less affordable for home users. Although nucleic acid hybridization and the antibody generation can be generalized for detection of nucleic acids and proteins, respectively, metabolites have been difficult to detect with a generalized method. Furthermore, although a colorimetric sensor is convenient and thus suitable for POC detection, it is vulnerable to interferences from colors in samples such as in blood. Fluorescent sensors, in contrast, have many advantages in sensitivity, accuracy, and time response, but the requirement of an excitation light source increases the size of the detector and costs of detection. Recently, Yu et al. have taken a major step toward addressing these issues (2), by developing a paper-based enzymatic assay method in which many metabolites can be quantified through oxidation by nicotinamide adenine dinucleotide phosphate (NADPH) (Fig. 1A), resulting in ratiometric changes in bioluminescence that can be quantified with a digital camera without a need for an excitation source. Fig. 1. Scheme of metabolite quantification by an engineered semisynthetic NADPH-dependent protein. A specific enzymatic reaction is performed in a reaction buffer to oxidize the analyte of interest by NADP+ (A). Design of a BRET sensor for NADPH (B). A protein chimera between a receptor and a luciferase (NanoLuc) is tethered via a SNAP-tag to a ligand derivatized with a fluorophore. NADPH triggers ligand binding to the receptor, thereby increasing …

Dose‐Dependent Response of Personal Glucose Meters to Nicotinamide Coenzymes: Applications to Point‐of‐Care Diagnostics of Many Non‐Glucose Targets in a Single Step

Integration of Solution-Based Assays Onto Lateral Flow Device for One-Step Quantitative Point-of-Care Diagnostics Using Personal Glucose Meter

Using Personal Glucose Meters and Functional DNA Sensors to Quantify a Variety of Analytical Targets.

Recent Advances of Using Personal Glucose Meter As a Biosensor Readout for Non-glucose Targets

Biocomputing for Portable, Resettable, and Quantitative Point-of-Care Diagnostics: Making the Glucose Meter a Logic-Gate Responsive Device for Measuring Many Clinically Relevant Targets

Advancing Point-of-Care Diagnostics of Metabolites Through Engineering Semisynthetic Proteins

Recent Developments in Personal Glucose Meters as Point-of-Care Testing Devices (2020–2024)

A polymer dot-based NADH-sensitive electrochemiluminescence biosensor for analysis of metabolites in serum

Using a Personal Glucose Meter and Alkaline Phosphatase for Point-of-Care Quantification of Galactose-1-Phosphate Uridyltransferase in Clinical Galactosemia Diagnosis.

Using Commercially Available Personal Glucose Meters for Portable Quantification of DNA.

Quantitative and Selective DNA Detection with Portable Personal Glucose Meter Using Loop-Based DNA Competitive Hybridization Strategy

Portable and sensitive detection of non-glucose target by enzyme-encapsulated metal-organic-framework using personal glucose meter

A flexible assay strategy for non-glucose targets based on sulfhydryl-terminated liposomes combined with personal glucometer

Direct glucose sensing in the physiological range through plasmonic nanoparticle formation

Using a Glucose Meter to Quantitatively Detect Disease Biomarkers Through a Universal Nanozyme Integrated Lateral Fluidic Sensing Platform.

A Conductive Hydrogel Microneedle-Based Assay Integrating PEDOT:PSS and Ag-Pt Nanoparticles for Real-Time, Enzyme-Less, and Electrochemical Sensing of Glucose

Point-of-care Testing of Protein Biomarkers by Integrating a Personal Glucose Meter with a Concatenated DNA Amplifier

Coenzyme Engineering of Glucose-6-phosphate Dehydrogenase on a Nicotinamide-Based Biomimic and Its Application as a Glucose Biosensor

Glucose detection: In-situ colorimetric analysis with double-layer hydrogel microneedle patch based on polyvinyl alcohol and carboxymethyl chitosan

Portable and Quantitative Detection of Protein Biomarkers and Small Molecular Toxins Using Antibodies and Ubiquitous Personal Glucose Meters.

An Exploration of Nucleic Acid Liquid Biopsy Using a Glucose Meter.